Wilson G B, Paddock G V, Floyd E, Newell R T, Dopson M H
Thymus. 1984;6(3):167-80.
Trypsinization of human T-lymphocytes removes surface receptors which bind to sheep erythrocytes (E). Human dialyzable leukocytes extracts (DLE) and thymosin (Fraction V) have been shown to significantly increase the rate of regeneration of T-lymphocyte E-receptors. Both physical-chemical and immunochemical results reported herein indicate that the enhancing effect of human DLE preparations on the rate of regeneration of T-lymphocyte E-receptors is due at least in part to the presence of thymosin alpha 1-peptide in these preparations. Thymosin alpha 1-peptide purified from thymosin Fraction V and putative thymosin alpha 1 preparations purified from human DLEs were each active not only in increasing the rate of regeneration of T-lymphocyte E-receptors removed by trypsinization but also were active in vitro in markedly increasing the number of E-rosetting cells in two patients with immunodeficiency disease manifested in part as a reduction in the normal percentage of mature T-lymphocytes capable of forming E-rosettes.
人T淋巴细胞经胰蛋白酶处理后会去除与绵羊红细胞(E)结合的表面受体。已证明人可透析白细胞提取物(DLE)和胸腺素(第五组分)能显著提高T淋巴细胞E受体的再生速率。本文报道的物理化学和免疫化学结果均表明,人DLE制剂对T淋巴细胞E受体再生速率的增强作用至少部分归因于这些制剂中存在胸腺素α1肽。从胸腺素第五组分中纯化的胸腺素α1肽以及从人DLE中纯化的假定胸腺素α1制剂不仅在提高经胰蛋白酶处理后去除的T淋巴细胞E受体的再生速率方面具有活性,而且在体外对两名免疫缺陷疾病患者中明显增加E花环形成细胞的数量也具有活性,这些患者部分表现为能够形成E花环的成熟T淋巴细胞的正常百分比降低。